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Abstract
Background: Aim was to determine the predictive factors for polypharmacy among inpatient
children and adolescents with psychiatric disorders.
Methods:  Blinded, case-note review of children and adolescents with ICD 10 diagnosis of
psychiatric disorders on psychotropic medication was conducted. Data on demography, illness, and
treatment was analyzed with univariate and multivariate techniques.
Results: Proscribing non-pharmacological interventions (OR = 4.7) and pro re nata medication (OR
= 3.3), increased the risk of polypharmacy. Prescribing physical restraint reduced the risk of
receiving multiple medications (OR = 0.3).
Conclusion: Proscribing non-pharmacological interventions, pro re nata medication and physical
restraints increased polypharmacy.
Background
Despite the pitfalls of advocating polypharmacy to chil-
dren and adolescents with psychiatric disorders [1], this
practice is alarmingly escalating [2]. This trend is pre-
dicted to increase with pharmacological treatments target-
ing symptoms without a clinical diagnosis, and when a
pursuit for treatment perfection with medication is
attempted [3]. Polypharmacy lacks safety or efficacy [4],
but increases the incidence of drug interactions [5]. There
is a need for research on polypharmacy in this population
[6]. This study aims to provide further information on the
risk factors associated with polypharmacy in the child and
adolescent, inpatient, psychiatry population.
Methods
Subjects included in the study (N = 268) were consecutive
admissions to the Child and Adolescent Psychiatry Unit,
Christian Medical College and Hospital (a tertiary care
centre), Vellore, from January 1997 to September 2001.
Children and adolescents below 18 years of age, with an
ICD-10 diagnosis (Clinical Guidelines Diagnostic Criteria
version) of psychiatric disorder and treated with at least
one psychotropic (excluding the anti-parkinsonian medi-
cation) were identified from unit registry. Reversible ano-
nymisation as well as restricted access and disclosure of
the obtained data ensured the privacy of patients. The
Institution's Ethics Committee approved this study. A psy-
chiatrist not part of the treating team reviewed the case-
notes for demographic, and illness details (independent
variables) made by the treating team during the time of
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admission prior to the design of this retrospective study.
Another psychiatrist blinded to the case note details col-
lected the treatment details from the inpatient admission-
discharge records (dependent variable). Only the last
admission was considered for subjects who were admitted
more than once during this period. There was no discern-
ible change in the prescribing pattern of psychotropics in
the unit because of any secular trend, change in institu-
tional protocol or any multiple-drug trial that was under-
way during this period. Information from these sources
was grouped as demographic variables (sex), illness varia-
bles (diagnoses, co-morbidity, psychotic symptoms) and
treatment variables (pro re nata medication, nonpharma-
cological intervention, physical restraint, side effects). Pro
re nata was operationalized as medication administered
on an 'as and when needed' basis. Nonpharmacological
intervention was defined in this study as the psychoedu-
cation about the nature of the illness and supportive psy-
chotherapy administered to the patient and family
Chi Square test, Mann-Whitney U test for comparison
between groups and logistic regression (enter method)
was used to assess the association of polypharmacy and
the three groups of variables. P < 0.05 (two-tailed) was
considered significant and data was analyzed with SPSS
(version 10.0).
Results and discussion
103 subjects were included in the study and the rest (N =
165) were excluded, as their psychiatric condition did not
require treatment with psychotropic medication (N =
152), or incomplete data set (N = 13). The sample mean
(sd) age and number of days spent in the hospital was
14.4 (2.6) years and 34.7 (10.9) days respectively. The
mean (sd) age difference in years between the monophar-
macy and polypharmacy groups was not statistically sig-
nificant [14.2(2.7) Vs. 14.7(2.6), Z = -1.05; P = 0.3]. The
disorders noted were mood disorders (n = 58), psychoses
(n = 33) and others (n = 12). About 49(47.6%) subjects
had single medication and 54 (52.4%) had multiple med-
ication where, 35(64.8%) had 2 psychotropic, 13(24.1%)
had 3 psychotropic, 5(9.3%) had 4 psychotropic, and
1(1.8%) had 5 psychotropic medications. There was no
statistically significant difference in the demographic, ill-
ness or treatment variables between groups.
Gender, diagnosis, comorbidity, psychotic symptoms,
side effects were not statistically significant in the logistic
regression models. Proscribing nonpharmacological treat-
ments was the strongest predictor of risk, and not pre-
scribing pro re nata medication also increased the risk for
polypharmacy. However, prescribing physical restraint
was protective in nature and reduced polpharmacy (Table
1).
The prevalence of polypharmacy in 52% of the popula-
tion in this study is less than the 60.3% reported previ-
ously [7] and proscription of non-pharmacological
therapy and pro re nata medication were identified as risk
factors for polypharmacy as their odds ratio was high. As
the odds ratio was around 1 for most of the other factors,
their contribution as a risk or protective factor could not
be predicted. However, prescribing physical restraint had
low odds ratio suggesting it being a protective factor.
Proscribing nonpharmacological therapies as a risk factor
is not surprising as non-pharmacological interventions
[8] like psycho education [9,10] when combined with
medication have resulted in a more rational use of medi-
cation and reduction of polypharmacy in previous stud-
ies.
However, in contrast to previous finding, pro re nata med-
ication has reduced polypharmacy. This is explained by
the treatment policy adopted in the facility, to convert and
add pro re nata doses (if required on more than two or
three occasions) to the existing regular medication
regime, resulting in reduced polypharmacy. However, pre-
dictive factors documented elsewhere and not included in
this study could have affected the results [11].
Beneficial effects of physical restraint reflect the protocol
followed in the unit to use physical restraint before chem-
ical restraint because the time spent in restraint is lesser
than the elimination half-lives of most of the psychotrop-
ics, reducing the risks associated with these medicines
[12]. Also, despite the existing negative attitude, the
advantages of physical restraint have to be considered in
assaultive and destructive children and adolescents [13].
The retrospective nature of the study limited our ability to
search for the presence of certain other risk factors of poly-
pharmacy and also it is possible that the small sample size
and only those with the most severe psychopathology
were on polypharmacy as inpatients compromising the
generalizability of the finding.
Conclusion
In conclusion these results suggest that proscribing non-
pharmacological interventions, pro re nata medication
and physical restraint increases the risk of polypharmacy
among children and adolescents with psychiatric disor-
ders. Therefore, prescribing non-pharmacological inter-
ventions,  pro re nata medication and physical restraint
might decrease the risk of polypharmacy. However, fur-
ther studies are needed to validate these findings along
with subgroup analysis of multi-class polypharmacy,
same-class polypharmacy, adjunctive polypharmacy and
augmentation strategies.Clinical Practice and Epidemiology in Mental Health 2006, 2:25 http://www.cpementalhealth.com/content/2/1/25
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Table 1: Association between risk factors and polypharmacy
Mono Pharmacy 
(n = 49)
Poly Pharmacy 
(n = 54)
Unadjusted OR df P Value Adjusted ORa 95% CI for OR P Value
n%n %
Demographic
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Diagnosis
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Yes 33 32 17 16.5 4.5 1 0.001 4.7 2.0 11.1 0.001
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Side effect
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No 19 34 22 26.2
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